CMIC：2024年在扩展的全球市场中通过临床合作伙伴关系增强现场支持报告（英文版）

The biopharma landscape is undergoing rapid global expansion, with increased competition and fast-paced technological innovation driving changes to R&D strategies. In response, biopharma companies are teaming up with contract research organizations (CROs) and site management organizations (SMOs) to support end-to-end clinical development operations, such as patient and site recruitment, which are crucial to accelerating trials and strengthening late-stage clinical success. Partnering and